US judge approves Purdue Pharma, Sacklers’ $6 billion settlement
A U.S. bankruptcy judge has approved the settlement Purdue Pharma and the Sackler families reached with a group of states that will require the Sacklers to pay up to $6 billion to states, individual plaintiffs and crisis relief opioids, Connecticut Attorney General William Tong announced Wednesday. The new agreement, reached earlier this month after eight states and the District of Columbia finally appealed a previous agreement, does not protect the Sackler families from future liability related to the opioid crisis. the extent of the suffering and damage caused by Purdue and the Sackler family,” Tong said in a statement. “But in reaching this $6 billion settlement, we recognized that we could not stall this process forever. for the victims and our sister states.” Tong added that there will be a hearing on Thursday that will give “victims and survivors the opportunity to speak directly to the Sacklers” and share in the damage and destruction they have caused. “We are not done fighting for justice against the addiction industry,” Tong said. As part of the agreement, the Sackler families will permit any institution or organization in the country to remove the Sackler name from physical facilities and academic, medical and cultural programs, scholarships and endowments as long as the Sacklers are notified first and the statements public announcements of the deletion of the name do not “disparage” the family. In a pre-drafted statement, the Sackler families said they were “gratified to have reached a settlement with additional states that will enable very substantial additional resources to reach people and communities in need.” members have argued that the settlement is by far the best way to help resolve a serious and complex public health crisis.While the families acted lawfully in all respects, they sincerely regret that OxyContin, a prescription drug which continues to help people with chronic pain, has unexpectedly been part of an opioid crisis that has caused heartache and loss to far too many families and communities,” he added. In a statement to CNN last week, Purdue Pharma also said it was happy with the settlement.
A U.S. bankruptcy judge has approved the settlement Purdue Pharma and the Sackler families reached with a group of states that will require the Sacklers to pay up to $6 billion to states, individual plaintiffs and crisis relief opioids, Connecticut Attorney General William Tong announced Wednesday. .
The new agreement, reached earlier this month after eight states and the District of Columbia finally appealed a previous agreement, does not protect the Sackler families from future liability related to the opioid crisis.
“No settlement will ever come close to remedying the magnitude of the suffering and damage caused by Purdue and the Sackler family,” Tong said in a statement. “But in reaching this $6 billion settlement, we recognized that we could not block this process forever for the victims and our sister states.”
Tong added that there will be a hearing on Thursday which will give “victims and survivors the opportunity to speak directly to the Sacklers and share in the damage and destruction they have caused.”
“We are not done fighting for justice against the addiction industry,” Tong said.
As part of the agreement, the Sackler families will authorize any institution or organization in the country to remove the Sackler name from physical facilities and academic, medical and cultural programs, scholarships and endowments as long as the Sacklers are notified first and that public statements announcing the estrangement’s name do not “disparage” the family.
In a pre-drafted statement, the Sackler families said they were “pleased to have reached a settlement with additional states that will allow very substantial additional resources to reach people and communities in need.”
“The families have consistently maintained that the settlement is by far the best way to help resolve a serious and complex public health crisis. Although the families acted lawfully in all respects, they sincerely regret that OxyContin, a drug on prescription that continues to help people with chronic pain, has unexpectedly become part of an opioid crisis that has caused heartbreak and loss to far too many families and communities,” he said. added.
In a statement to CNN last week, Purdue Pharma also said it was happy with the settlement.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CYTHGHY2CRK2LFZNGZ2VJ2YMAE.jpg)
